Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 80049120113

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80049120113 and manufactured by ALAMAR TECNO CIENTÍFICA LTDA. The registration is held by ALAMAR TECNO CIENTÍFICA LTDA with validity until May 30, 2032.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80049120113
Registration Details
ANVISA Registration Number: 80049120113
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

VERIFIK®COVID Autoteste para detecção de Antígeno SARS-CoV-2 em amostra Nasal
Risk Class III

Registration Details

80049120113

25351106474202229

48044358000142

Company Information

Brazil
PT: BRASIL

Dates and Status

May 30, 2022

30/05/2032

09/18/2025 19:00:01